Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
34
CDNA.TO Quote, Financials, Valuation and Earnings
Last price:
$15.77
Seasonality move
:
-1.2%
Day range:
$15.77 - $15.77
52-week range:
$15.12 - $17.85
Dividend yield:
0.63%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
--
Avg. volume:
407
1-year change:
-9.89%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
CDNA.TO
CI Bio-Revolution Index ETF
|
-- | -- | -- | -- | -- |
|
FHH.TO
First Trust AlphaDEX™ US Hlth Care Sector Idx ETF
|
-- | -- | -- | -- | -- |
|
HLIT.TO
Global X Lithium Producers Index ETF
|
-- | -- | -- | -- | -- |
|
XCLN.TO
iShares Global Clean Energy Index ETF
|
-- | -- | -- | -- | -- |
|
XDNA.TO
iShares Genomics Immunology and Healthcare Idx ETF
|
-- | -- | -- | -- | -- |
|
ZUH.TO
BMO Equal Weight US Health Care Hgd to CAD Idx ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
CDNA.TO
CI Bio-Revolution Index ETF
|
$15.77 | -- | -- | -- | $0.02 | 0.63% | -- |
|
FHH.TO
First Trust AlphaDEX™ US Hlth Care Sector Idx ETF
|
$40.84 | -- | -- | -- | $0.03 | 0.29% | -- |
|
HLIT.TO
Global X Lithium Producers Index ETF
|
$14.90 | -- | -- | -- | $0.70 | 4.72% | -- |
|
XCLN.TO
iShares Global Clean Energy Index ETF
|
$27.42 | -- | -- | -- | $0.20 | 1.06% | -- |
|
XDNA.TO
iShares Genomics Immunology and Healthcare Idx ETF
|
$34.60 | -- | -- | -- | $0.10 | 0.28% | -- |
|
ZUH.TO
BMO Equal Weight US Health Care Hgd to CAD Idx ETF
|
$66.61 | -- | -- | -- | $0.51 | 0.76% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
CDNA.TO
CI Bio-Revolution Index ETF
|
-- | 0.759 | -- | -- |
|
FHH.TO
First Trust AlphaDEX™ US Hlth Care Sector Idx ETF
|
-- | 0.781 | -- | -- |
|
HLIT.TO
Global X Lithium Producers Index ETF
|
-- | 1.542 | -- | -- |
|
XCLN.TO
iShares Global Clean Energy Index ETF
|
-- | 1.399 | -- | -- |
|
XDNA.TO
iShares Genomics Immunology and Healthcare Idx ETF
|
-- | 1.050 | -- | -- |
|
ZUH.TO
BMO Equal Weight US Health Care Hgd to CAD Idx ETF
|
-- | 0.877 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
CDNA.TO
CI Bio-Revolution Index ETF
|
-- | -- | -- | -- | -- | -- |
|
FHH.TO
First Trust AlphaDEX™ US Hlth Care Sector Idx ETF
|
-- | -- | -- | -- | -- | -- |
|
HLIT.TO
Global X Lithium Producers Index ETF
|
-- | -- | -- | -- | -- | -- |
|
XCLN.TO
iShares Global Clean Energy Index ETF
|
-- | -- | -- | -- | -- | -- |
|
XDNA.TO
iShares Genomics Immunology and Healthcare Idx ETF
|
-- | -- | -- | -- | -- | -- |
|
ZUH.TO
BMO Equal Weight US Health Care Hgd to CAD Idx ETF
|
-- | -- | -- | -- | -- | -- |
CI Bio-Revolution Index ETF vs. Competitors
-
Which has Higher Returns CDNA.TO or FHH.TO?
First Trust AlphaDEX™ US Hlth Care Sector Idx ETF has a net margin of -- compared to CI Bio-Revolution Index ETF's net margin of --. CI Bio-Revolution Index ETF's return on equity of -- beat First Trust AlphaDEX™ US Hlth Care Sector Idx ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital CDNA.TOCI Bio-Revolution Index ETF-- -- -- FHH.TOFirst Trust AlphaDEX™ US Hlth Care Sector Idx ETF-- -- -- -
What do Analysts Say About CDNA.TO or FHH.TO?
CI Bio-Revolution Index ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust AlphaDEX™ US Hlth Care Sector Idx ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that CI Bio-Revolution Index ETF has higher upside potential than First Trust AlphaDEX™ US Hlth Care Sector Idx ETF, analysts believe CI Bio-Revolution Index ETF is more attractive than First Trust AlphaDEX™ US Hlth Care Sector Idx ETF.
Company Buy Ratings Hold Ratings Sell Ratings CDNA.TOCI Bio-Revolution Index ETF0 0 0 FHH.TOFirst Trust AlphaDEX™ US Hlth Care Sector Idx ETF0 0 0 -
Is CDNA.TO or FHH.TO More Risky?
CI Bio-Revolution Index ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison First Trust AlphaDEX™ US Hlth Care Sector Idx ETF has a beta of 0.548, suggesting its less volatile than the S&P 500 by 45.213%.
-
Which is a Better Dividend Stock CDNA.TO or FHH.TO?
CI Bio-Revolution Index ETF has a quarterly dividend of $0.02 per share corresponding to a yield of 0.63%. First Trust AlphaDEX™ US Hlth Care Sector Idx ETF offers a yield of 0.29% to investors and pays a quarterly dividend of $0.03 per share. CI Bio-Revolution Index ETF pays -- of its earnings as a dividend. First Trust AlphaDEX™ US Hlth Care Sector Idx ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CDNA.TO or FHH.TO?
CI Bio-Revolution Index ETF quarterly revenues are --, which are smaller than First Trust AlphaDEX™ US Hlth Care Sector Idx ETF quarterly revenues of --. CI Bio-Revolution Index ETF's net income of -- is lower than First Trust AlphaDEX™ US Hlth Care Sector Idx ETF's net income of --. Notably, CI Bio-Revolution Index ETF's price-to-earnings ratio is -- while First Trust AlphaDEX™ US Hlth Care Sector Idx ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CI Bio-Revolution Index ETF is -- versus -- for First Trust AlphaDEX™ US Hlth Care Sector Idx ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CDNA.TOCI Bio-Revolution Index ETF-- -- -- -- FHH.TOFirst Trust AlphaDEX™ US Hlth Care Sector Idx ETF-- -- -- --
-
Which has Higher Returns CDNA.TO or HLIT.TO?
Global X Lithium Producers Index ETF has a net margin of -- compared to CI Bio-Revolution Index ETF's net margin of --. CI Bio-Revolution Index ETF's return on equity of -- beat Global X Lithium Producers Index ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital CDNA.TOCI Bio-Revolution Index ETF-- -- -- HLIT.TOGlobal X Lithium Producers Index ETF-- -- -- -
What do Analysts Say About CDNA.TO or HLIT.TO?
CI Bio-Revolution Index ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X Lithium Producers Index ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that CI Bio-Revolution Index ETF has higher upside potential than Global X Lithium Producers Index ETF, analysts believe CI Bio-Revolution Index ETF is more attractive than Global X Lithium Producers Index ETF.
Company Buy Ratings Hold Ratings Sell Ratings CDNA.TOCI Bio-Revolution Index ETF0 0 0 HLIT.TOGlobal X Lithium Producers Index ETF0 0 0 -
Is CDNA.TO or HLIT.TO More Risky?
CI Bio-Revolution Index ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Global X Lithium Producers Index ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock CDNA.TO or HLIT.TO?
CI Bio-Revolution Index ETF has a quarterly dividend of $0.02 per share corresponding to a yield of 0.63%. Global X Lithium Producers Index ETF offers a yield of 4.72% to investors and pays a quarterly dividend of $0.70 per share. CI Bio-Revolution Index ETF pays -- of its earnings as a dividend. Global X Lithium Producers Index ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CDNA.TO or HLIT.TO?
CI Bio-Revolution Index ETF quarterly revenues are --, which are smaller than Global X Lithium Producers Index ETF quarterly revenues of --. CI Bio-Revolution Index ETF's net income of -- is lower than Global X Lithium Producers Index ETF's net income of --. Notably, CI Bio-Revolution Index ETF's price-to-earnings ratio is -- while Global X Lithium Producers Index ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CI Bio-Revolution Index ETF is -- versus -- for Global X Lithium Producers Index ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CDNA.TOCI Bio-Revolution Index ETF-- -- -- -- HLIT.TOGlobal X Lithium Producers Index ETF-- -- -- --
-
Which has Higher Returns CDNA.TO or XCLN.TO?
iShares Global Clean Energy Index ETF has a net margin of -- compared to CI Bio-Revolution Index ETF's net margin of --. CI Bio-Revolution Index ETF's return on equity of -- beat iShares Global Clean Energy Index ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital CDNA.TOCI Bio-Revolution Index ETF-- -- -- XCLN.TOiShares Global Clean Energy Index ETF-- -- -- -
What do Analysts Say About CDNA.TO or XCLN.TO?
CI Bio-Revolution Index ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares Global Clean Energy Index ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that CI Bio-Revolution Index ETF has higher upside potential than iShares Global Clean Energy Index ETF, analysts believe CI Bio-Revolution Index ETF is more attractive than iShares Global Clean Energy Index ETF.
Company Buy Ratings Hold Ratings Sell Ratings CDNA.TOCI Bio-Revolution Index ETF0 0 0 XCLN.TOiShares Global Clean Energy Index ETF0 0 0 -
Is CDNA.TO or XCLN.TO More Risky?
CI Bio-Revolution Index ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison iShares Global Clean Energy Index ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock CDNA.TO or XCLN.TO?
CI Bio-Revolution Index ETF has a quarterly dividend of $0.02 per share corresponding to a yield of 0.63%. iShares Global Clean Energy Index ETF offers a yield of 1.06% to investors and pays a quarterly dividend of $0.20 per share. CI Bio-Revolution Index ETF pays -- of its earnings as a dividend. iShares Global Clean Energy Index ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CDNA.TO or XCLN.TO?
CI Bio-Revolution Index ETF quarterly revenues are --, which are smaller than iShares Global Clean Energy Index ETF quarterly revenues of --. CI Bio-Revolution Index ETF's net income of -- is lower than iShares Global Clean Energy Index ETF's net income of --. Notably, CI Bio-Revolution Index ETF's price-to-earnings ratio is -- while iShares Global Clean Energy Index ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CI Bio-Revolution Index ETF is -- versus -- for iShares Global Clean Energy Index ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CDNA.TOCI Bio-Revolution Index ETF-- -- -- -- XCLN.TOiShares Global Clean Energy Index ETF-- -- -- --
-
Which has Higher Returns CDNA.TO or XDNA.TO?
iShares Genomics Immunology and Healthcare Idx ETF has a net margin of -- compared to CI Bio-Revolution Index ETF's net margin of --. CI Bio-Revolution Index ETF's return on equity of -- beat iShares Genomics Immunology and Healthcare Idx ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital CDNA.TOCI Bio-Revolution Index ETF-- -- -- XDNA.TOiShares Genomics Immunology and Healthcare Idx ETF-- -- -- -
What do Analysts Say About CDNA.TO or XDNA.TO?
CI Bio-Revolution Index ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares Genomics Immunology and Healthcare Idx ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that CI Bio-Revolution Index ETF has higher upside potential than iShares Genomics Immunology and Healthcare Idx ETF, analysts believe CI Bio-Revolution Index ETF is more attractive than iShares Genomics Immunology and Healthcare Idx ETF.
Company Buy Ratings Hold Ratings Sell Ratings CDNA.TOCI Bio-Revolution Index ETF0 0 0 XDNA.TOiShares Genomics Immunology and Healthcare Idx ETF0 0 0 -
Is CDNA.TO or XDNA.TO More Risky?
CI Bio-Revolution Index ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison iShares Genomics Immunology and Healthcare Idx ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock CDNA.TO or XDNA.TO?
CI Bio-Revolution Index ETF has a quarterly dividend of $0.02 per share corresponding to a yield of 0.63%. iShares Genomics Immunology and Healthcare Idx ETF offers a yield of 0.28% to investors and pays a quarterly dividend of $0.10 per share. CI Bio-Revolution Index ETF pays -- of its earnings as a dividend. iShares Genomics Immunology and Healthcare Idx ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CDNA.TO or XDNA.TO?
CI Bio-Revolution Index ETF quarterly revenues are --, which are smaller than iShares Genomics Immunology and Healthcare Idx ETF quarterly revenues of --. CI Bio-Revolution Index ETF's net income of -- is lower than iShares Genomics Immunology and Healthcare Idx ETF's net income of --. Notably, CI Bio-Revolution Index ETF's price-to-earnings ratio is -- while iShares Genomics Immunology and Healthcare Idx ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CI Bio-Revolution Index ETF is -- versus -- for iShares Genomics Immunology and Healthcare Idx ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CDNA.TOCI Bio-Revolution Index ETF-- -- -- -- XDNA.TOiShares Genomics Immunology and Healthcare Idx ETF-- -- -- --
-
Which has Higher Returns CDNA.TO or ZUH.TO?
BMO Equal Weight US Health Care Hgd to CAD Idx ETF has a net margin of -- compared to CI Bio-Revolution Index ETF's net margin of --. CI Bio-Revolution Index ETF's return on equity of -- beat BMO Equal Weight US Health Care Hgd to CAD Idx ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital CDNA.TOCI Bio-Revolution Index ETF-- -- -- ZUH.TOBMO Equal Weight US Health Care Hgd to CAD Idx ETF-- -- -- -
What do Analysts Say About CDNA.TO or ZUH.TO?
CI Bio-Revolution Index ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand BMO Equal Weight US Health Care Hgd to CAD Idx ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that CI Bio-Revolution Index ETF has higher upside potential than BMO Equal Weight US Health Care Hgd to CAD Idx ETF, analysts believe CI Bio-Revolution Index ETF is more attractive than BMO Equal Weight US Health Care Hgd to CAD Idx ETF.
Company Buy Ratings Hold Ratings Sell Ratings CDNA.TOCI Bio-Revolution Index ETF0 0 0 ZUH.TOBMO Equal Weight US Health Care Hgd to CAD Idx ETF0 0 0 -
Is CDNA.TO or ZUH.TO More Risky?
CI Bio-Revolution Index ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison BMO Equal Weight US Health Care Hgd to CAD Idx ETF has a beta of 0.849, suggesting its less volatile than the S&P 500 by 15.061%.
-
Which is a Better Dividend Stock CDNA.TO or ZUH.TO?
CI Bio-Revolution Index ETF has a quarterly dividend of $0.02 per share corresponding to a yield of 0.63%. BMO Equal Weight US Health Care Hgd to CAD Idx ETF offers a yield of 0.76% to investors and pays a quarterly dividend of $0.51 per share. CI Bio-Revolution Index ETF pays -- of its earnings as a dividend. BMO Equal Weight US Health Care Hgd to CAD Idx ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CDNA.TO or ZUH.TO?
CI Bio-Revolution Index ETF quarterly revenues are --, which are smaller than BMO Equal Weight US Health Care Hgd to CAD Idx ETF quarterly revenues of --. CI Bio-Revolution Index ETF's net income of -- is lower than BMO Equal Weight US Health Care Hgd to CAD Idx ETF's net income of --. Notably, CI Bio-Revolution Index ETF's price-to-earnings ratio is -- while BMO Equal Weight US Health Care Hgd to CAD Idx ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CI Bio-Revolution Index ETF is -- versus -- for BMO Equal Weight US Health Care Hgd to CAD Idx ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CDNA.TOCI Bio-Revolution Index ETF-- -- -- -- ZUH.TOBMO Equal Weight US Health Care Hgd to CAD Idx ETF-- -- -- --
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
